GEMPHIRE THERAPEUTICS INC's ticker is GEMP and the CUSIP is 36870A108. A total of 29 filers reported holding GEMPHIRE THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $67,000 | -52.5% | 176,544 | +1.4% | 0.00% | 0.0% |
| Q2 2019 | $141,000 | -29.1% | 174,044 | +0.6% | 0.00% | -50.0% |
| Q1 2019 | $199,000 | +43.2% | 173,044 | +0.6% | 0.00% | 0.0% |
| Q4 2018 | $139,000 | -60.7% | 172,044 | 0.0% | 0.00% | -33.3% |
| Q3 2018 | $354,000 | -79.2% | 172,044 | +2.8% | 0.00% | -83.3% |
| Q2 2018 | $1,705,000 | +56.9% | 167,364 | +0.2% | 0.02% | +50.0% |
| Q1 2018 | $1,087,000 | -13.9% | 166,964 | +5.0% | 0.01% | -20.0% |
| Q4 2017 | $1,263,000 | -16.9% | 158,964 | -0.6% | 0.02% | -25.0% |
| Q3 2017 | $1,520,000 | -22.4% | 159,964 | +4.5% | 0.02% | -31.0% |
| Q2 2017 | $1,959,000 | +23.9% | 153,064 | +1.7% | 0.03% | +7.4% |
| Q1 2017 | $1,581,000 | – | 150,564 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Exchange Capital Management, Inc. | 758,623 | $7,966,000 | 2.88% |
| Cormorant Asset Management, LP | 952,798 | $10,004,000 | 1.45% |
| DAFNA Capital Management LLC | 52,797 | $554,000 | 0.47% |
| HIGHLAND CAPITAL MANAGEMENT LP | 316,789 | $3,326,000 | 0.17% |
| Cambridge Investment Research Advisors, Inc. | 150,564 | $1,581,000 | 0.03% |
| NORRIS PERNE & FRENCH LLP/MI | 10,463 | $110,000 | 0.02% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 634,246 | $6,660,000 | 0.02% |
| SEGALL BRYANT & HAMILL, LLC | 11,000 | $116,000 | 0.00% |
| Acrospire Investment Management LLC | 400 | $4,000 | 0.00% |
| Advisor Group, Inc. | 5,112 | $54,000 | 0.00% |